June 17th, 2021, Holliston, MA, USA - Oligo Factory, a provider of quality custom DNA/RNA synthesis services, announced plans to develop the next level custom oligonucleotide synthesizer. The project, designated QMaster 400, will be capable of producing 200 grams of oligonucleotide, up to 40 nucleic acid bases in length, per day. This platform will augment and compliment Oligo Factory’s current capability presently fulfilled by the QMaster GS and QMaster AVA systems which prepare up to 10 grams of purified synthetic oligonucleotide. The synthesizer line, running on Validate Software, will provide a continuum of mass requirements from 100mg to 200 grams of purified product. These platforms and this next level platform currently satisfy the needs of oligonucleotide researchers migrating from analytical to process scales.
Oligo Factory is a synthesis service facility that differentiates itself by providing state-of-the-art capability and high quality, through innovation in the area of custom synthesizer development. The founders of Oligo Factory are pioneers of synthesizer design with a history going back four decades. The most recent system, the QMaster AVA project, was launched last fall and went online in February. The new next level QMaster 400 system will be a substantial development effort with a five to six month launch window. This expedited effort is to meet the needs of accelerating viral diagnostic and mRNA research.
Founded in 2006, Oligo Factory, a privately held Massachusetts Corporation, serves researchers who require intermediate to large scale quantities of synthetic DNA/RNA typically used in biological research, diagnostics and drug discovery. The company synthesizes oligos with a wide range of modifications. Anion-exchange liquid chromatography is primarily used for purification as well as high performance multi-stage ultrafiltration for kilogram scale projects.